International Forum of Allergy & Rhinology

Scope & Guideline

Uncovering Breakthroughs in Allergy and Rhinology

Introduction

Welcome to the International Forum of Allergy & Rhinology information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of International Forum of Allergy & Rhinology, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2042-6976
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2011 to 2024
AbbreviationINT FORUM ALLERGY RH / Int. Forum Allergy Rhinol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The International Forum of Allergy & Rhinology focuses on the comprehensive study of diseases affecting the nasal and sinus regions, with a strong emphasis on allergic and inflammatory conditions. The journal aims to disseminate cutting-edge research that enhances clinical practice and patient care in rhinology, allergy, and related fields.
  1. Chronic Rhinosinusitis Research:
    The journal consistently publishes studies that explore various aspects of chronic rhinosinusitis (CRS), including its pathophysiology, treatment modalities, and the role of biologics in management.
  2. Allergic Rhinitis and Immunotherapy:
    There is a strong focus on allergic rhinitis, including studies on immunotherapy, novel treatment approaches, and the impact of environmental factors on allergic responses.
  3. Olfactory Dysfunction Studies:
    Research on olfactory dysfunction, particularly as it relates to chronic conditions and post-viral syndromes, is a core area of interest, with an emphasis on diagnostic and therapeutic advancements.
  4. Surgical Innovations in Rhinology:
    The journal highlights advancements in surgical techniques for sinus and nasal procedures, including endoscopic surgeries, and their outcomes, reflecting a commitment to improving surgical care.
  5. Epidemiological and Health Disparities Research:
    There is a notable interest in studies that examine the epidemiology of rhinological conditions and the impact of socioeconomic factors on patient outcomes.
  6. Utilization of Artificial Intelligence and Machine Learning:
    Recent publications indicate an emerging trend towards the use of AI and machine learning in diagnostics and treatment planning within rhinology, showcasing innovative methodologies.
The journal has adapted to the evolving landscape of rhinology and allergy research, with emerging themes reflecting current challenges and advancements in the field.
  1. Impact of COVID-19 on Olfactory Function:
    There is a significant increase in research exploring the effects of COVID-19 on olfactory dysfunction, highlighting the pandemic's lasting impact on rhinology.
  2. Biologics and Targeted Therapies:
    A clear trend towards the exploration of biologics and targeted therapies for chronic rhinosinusitis and allergic conditions is evident, with numerous studies assessing their efficacy and safety.
  3. Integration of Telemedicine in Rhinology:
    The incorporation of telemedicine and digital health solutions in managing rhinological conditions has gained traction, especially in light of the COVID-19 pandemic.
  4. Patient-Centered Outcomes and Quality of Life:
    Research focusing on patient-reported outcomes, quality of life assessments, and shared decision-making in treatment plans is increasingly prominent, emphasizing patient engagement.
  5. Environmental and Socioeconomic Factors:
    Emerging studies are examining the influence of environmental exposures and socioeconomic determinants on rhinological health, reflecting a broader understanding of health disparities.
  6. Artificial Intelligence in Diagnostics:
    The application of AI and machine learning in diagnostic processes and treatment planning is on the rise, signaling a shift towards more technologically advanced methodologies in rhinology.

Declining or Waning

While the journal has seen growth in several areas, certain themes appear to be declining in prominence, reflecting shifts in research focus and clinical priorities.
  1. Traditional Pharmacological Treatments:
    There has been a noticeable decrease in studies focused exclusively on traditional pharmacological treatments for sinusitis and allergies, as interest shifts towards biologics and novel therapies.
  2. Basic Science Research:
    The volume of purely basic science research related to rhinology is waning, as the journal moves towards more clinical and applied research that directly impacts patient care.
  3. Focus on Historical Perspectives:
    Papers providing historical perspectives or reviews of older treatment modalities are becoming less common, as the emphasis is increasingly on contemporary practices and innovations.
  4. Epidemiological Studies without Clinical Application:
    Research that presents epidemiological data without clear clinical implications or actionable insights is less frequently featured, prioritizing studies that can directly inform practice.

Similar Journals

Therapeutic Advances in Allergy and Rhinology

Exploring new frontiers in nasal health and allergy management.
Publisher: SAGE PUBLICATIONS INCISSN: 2753-4030Frequency: 1 issue/year

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

World Allergy Organization Journal

Elevating Standards in Allergy Research and Treatment
Publisher: ELSEVIERISSN: 1939-4551Frequency: 12 issues/year

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

CLINICAL AND EXPERIMENTAL ALLERGY

Leading the Charge in Allergy Research Excellence
Publisher: WILEYISSN: 0954-7894Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

ALLERGY AND ASTHMA PROCEEDINGS

Exploring breakthroughs in respiratory health.
Publisher: OCEAN SIDE PUBLICATIONS INCISSN: 1088-5412Frequency: 6 issues/year

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.

Bangladesh Journal of Otorhinolaryngology

Enhancing global discourse in ENT healthcare.
Publisher: SOC OTORHINOLARYNGOLOGISTS & HEAD NECK SURGEONS BANGLADESHISSN: 1728-8835Frequency: 2 issues/year

Bangladesh Journal of Otorhinolaryngology is a prominent peer-reviewed journal dedicated to the field of otorhinolaryngology, providing a platform for the dissemination of innovative research and clinical findings related to ear, nose, and throat (ENT) disorders. Published by the SOC OTORHINOLARYNGOLOGISTS & HEAD NECK SURGEONS BANGLADESH, the journal aims to enhance medical knowledge, improve clinical practices, and promote evidence-based treatments among healthcare professionals. As an academic resource, it serves not only local but also international audiences, facilitating a deeper understanding of the challenges and advancements in ENT healthcare. Although published in Bangladesh, the journal's rigorous peer-review process and commitment to high academic standards position it as a significant contributor to global ENT research discourse. While currently not an open-access journal, it encourages subscription and institutional access, helping researchers and practitioners stay abreast of cutting-edge developments in the field.

Allergy Asthma & Immunology Research

Elevating the discourse in immunology and respiratory medicine.
Publisher: KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGYISSN: 2092-7355Frequency: 6 issues/year

Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Connecting Scholars for Groundbreaking Discoveries
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-8561Frequency: 4 issues/year

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the dynamic fields of immunology and allergy. With an ISSN of 0889-8561 and an E-ISSN of 1557-8607, this journal has consistently ranked in the Q2 category in both Immunology and Immunology and Allergy as per 2023 metrics, underscoring its critical role in academia. It provides cutting-edge research, comprehensive reviews, and practical insights that cater to the needs of researchers, clinicians, and students alike. Though the journal is not open access, it remains an essential resource for those involved in advancing knowledge and clinical practice in allergy and immunology. With its converged years stretching from 1987 to 2024, the journal serves as a rich repository of scientific advancements, fostering progress in diagnosis, treatment, and prevention of allergic diseases and immune disorders. Positioned within the United States and based in Philadelphia, it plays a vital role in promoting scholarly communication within these impactful fields.

Revue Francaise d Allergologie

Pioneering Discoveries in Immunology and Allergy
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1877-0320Frequency: 8 issues/year

The Revue Francaise d'Allergologie, an esteemed publication in the field of Immunology and Allergy, is published by ELSEVIER MASSON, CORP OFF in France. This journal plays a pivotal role in disseminating significant findings and advancements in allergy research and immunotherapy, reflecting the latest trends and challenges in these rapidly evolving areas. As part of its commitment to scholarly rigor, the journal encompasses a wide range of topics pertinent to allergology, aiming to bridge the gap between clinical practice and academic research. Although currently not listed as open access, it provides critical insights essential for researchers, professionals, and students alike, ensuring the advancement of knowledge and therapeutic strategies in allergy and immunology. With its impact factor and positioning in the Q4 category, it serves as a valuable resource, aiding in the education and development of future leaders in the field. The Revue Francaise d'Allergologie continues to be a vital platform for the exchange of innovative ideas and findings from 2009 to the present.

Journal of Allergy and Clinical Immunology-In Practice

Exploring the forefront of allergy and immunology.
Publisher: ELSEVIERISSN: 2213-2198Frequency: 6 issues/year

The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.

Allergo Journal

Pioneering insights into immune responses.
Publisher: SPRINGER HEIDELBERGISSN: 0941-8849Frequency: 8 issues/year

Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.